U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
ETESEVIMAB
N7Q9NLF11I
Possibly Marketed Outside US
First approved in 2021
General
Record Details
Names
18
Identifiers
8
Subunits
4
Disulfide Links
16
Glycosylation
2
Relationships
2
Active Moiety
1
Characteristic Attributes
2
ETESEVIMAB
N7Q9NLF11I
Possibly Marketed Outside US
First approved in 2021
General
Approval Year
2021
470
Record Details
Substance Class
Protein
Protein Type
MONOCLONAL ANTIBODY
Protein Sub Type
IGG1
Sequence Origin
HUMAN
Record UNII
N7Q9NLF11I
Record Status
Validated (UNII)
Record Version
24
23
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
18
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
LY-3832479
Preferred Name
English
ETESEVIMAB
Official Name
English
ANTI-SARS-COV-2 ANTIBODY JS016
Common Name
English
CB6
Code
English
JS016
Code
English
Showing 1 to 5 of 18 entries
Previous
1
2
3
4
Next
Identifiers
8
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CAS
2423948-94-9
PRIMARY
INN
11873
PRIMARY
FDA UNII
N7Q9NLF11I
PRIMARY
RXCUI
2477854
PRIMARY
SMS_ID
300000026913
PRIMARY
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Subunits
4
Disulfide Links
16
Show
5
20
100
All
entries
From
To
From
To
4_136
4_196
4_23
4_88
3_136
3_196
3_23
3_88
2_369
2_427
Showing 1 to 5 of 16 entries
Previous
1
2
3
4
Next
Glycosylation
2
Glycosylation Type
MAMMALIAN
Show
5
20
100
All
entries
Glycosylation Link Type
Site
Glycosylation Link Type
Site
N
1_299
N
2_299
Showing 1 to 2 of 2 entries
Previous
1
Next
Relationships
2
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
0EO1SV3LKY
SPIKE-1 PROTEIN SARS-COV-2
TARGET->LIGAND
Comments:
Blocks attachment of the virus to human angiotensin-converting enzyme 2 (ACE2) receptors, preventing subsequent viral entry into human cells and viral replication.
Amount:
B6L4N5Z4GH
SARS-COV2
TARGET ORGANISM->INHIBITOR
Amount:
Showing 1 to 2 of 2 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
N7Q9NLF11I
ETESEVIMAB
ACTIVE MOIETY
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
MOL_WEIGHT:NUMBER(CALCULATED)
CHEMICAL
ESTIMATED 145000 Da (average)
Molecular Formula
CHEMICAL
ESTIMATED
C6436H9984O2016N1712S48
Showing 1 to 2 of 2 entries
Previous
1
Next
